XML 59 R36.htm IDEA: XBRL DOCUMENT
v3.24.1.u1

Stockholders' Equity (Deficit) (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2024
Stockholders' Equity Note [Abstract] |
Schedule of change in the number of shares of Class A common stock | The following tables present certain information regarding our stockholders’ equity as of March 31, 2024 and 2023:
| Three Months Ended March 31, 2024
| Common Stock |  | Additional Paid in Capital |  | Retained Earnings |  | Treasury Stock |  | Accumulated Other Comprehensive Loss |  |  |  | Total
January 1, 2024 | $ | 1 |  |  | $ | 1,118 |  |  | $ | 680 |  |  | $ | (751) |  |  | $ | (283) |  |  |  |  | $ | 765 |
Settlement of liability awards | — |  |  | 65 |  |  | — |  |  | — |  |  | — |  |  |  |  | 65 |
Vesting of RSUs, net of tax withholdings and other | — |  |  | (43) |  |  | — |  |  | — |  |  | — |  |  |  |  | (43) |
Purchase of treasury stock | — |  |  | — |  |  | — |  |  | (25) |  |  | — |  |  |  |  | (25) |
Stock-based compensation | — |  |  | 14 |  |  | — |  |  | — |  |  | — |  |  |  |  | 14 |
Net income | — |  |  | — |  |  | 82 |  |  | — |  |  | — |  |  |  |  | 82 |
Other comprehensive loss | — |  |  | — |  |  | — |  |  | — |  |  | (23) |  |  |  |  | (23) |
March 31, 2024 | $ | 1 |  |  | $ | 1,154 |  |  | $ | 762 |  |  | $ | (776) |  |  | $ | (306) |  |  |  |  | $ | 835 |
| Three Months Ended March 31, 2023
| Common Stock |  | Additional Paid in Capital |  | Accumulated Loss |  | Treasury Stock |  | Accumulated Other Comprehensive Loss |  | Noncontrolling Interest |  | Total
January 1, 2023 | $ | 1 |  |  | $ | 1,370 |  |  | $ | 517 |  |  | $ | (580) |  |  | $ | (318) |  |  | $ | 171 |  |  | $ | 1,161 |
Settlement of liability awards | — |  |  | 25 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 25 |
Vesting of RSUs, net of tax withholdings and other | — |  |  | (14) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (14) |
Purchase of treasury stock | — |  |  | — |  |  | — |  |  | (28) |  |  | — |  |  | — |  |  | (28) |
Purchase of SciPlay’s Class A common stock | — |  |  | (8) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (8) |
Stock-based compensation | — |  |  | 15 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 15 |
Net income | — |  |  | — |  |  | 22 |  |  | — |  |  | — |  |  | 5 |  |  | 27 |
Other comprehensive income | — |  |  | — |  |  | — |  |  | — |  |  | 6 |  |  | — |  |  | 6 |
March 31, 2023 | $ | 1 |  |  | $ | 1,388 |  |  | $ | 539 |  |  | $ | (608) |  |  | $ | (312) |  |  | $ | 176 |  |  | $ | 1,184 |
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award | The following reflects total stock-based compensation expense recognized under all programs:
|  |  | Three Months Ended March 31,
|  |  |  |  | 2024 |  | 2023 |  |
Related to L&W RSUs |  |  |  |  | $ | 22 |  |  | $ | 19 |  |  |
Related to SciPlay RSUs |  |  |  |  | — |  |  | 7 |  |  |
Total(1) |  |  |  |  | $ | 22 |  |  | $ | 26 |  |  |
(1) Includes $8 million and $11 million of stock-based compensation classified as liability awards as of March 31, 2024 and 2023, respectively.
RSUs outstanding under equity-based compensation plans | A summary of the changes in RSUs outstanding under our equity-based compensation plans during the three months ended March 31, 2024 is presented below:
| Number of Restricted Stock Units |  | Weighted Average Grant Date Fair Value
Unvested RSUs as of December 31, 2023 | 2.3 |  |  | $ | 55.53 |
Granted | 1.3 |  |  | $ | 99.65 |
Vested | (1.2) |  |  | $ | 73.52 |
Cancelled | — |  |  | $ | 49.73 |
Unvested RSUs as of March 31, 2024 | 2.4 |  |  | $ | 71.10 |

X
- Definition Tabular disclosure of share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 1 -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-1 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year. + References No definition available. + Details
Name: | us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of changes in the separate accounts comprising stockholders' equity (in addition to retained earnings) and of the changes in the number of shares of equity securities during at least the most recent annual fiscal period and any subsequent interim period presented is required to make the financial statements sufficiently informative if both financial position and results of operations are presented. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -SubTopic 10 -Topic 505 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration